Tag Archives: CSL Limited

Novartis to divest its influenza vaccines business to CSL Limited (CSL) for USD 275 million

Posted on 28, October 2014 by

CSL to acquire Novartis influenza vaccines business, including development pipeline, for USD 275 million Announcement follows a transaction announced on April 22, 2014 to divest the non-influenza segments of Novartis Vaccines to GlaxoSmithKline Basel, Switzerland, 28-10-2014 — /EuropaWire/ — Novartis today … Read the full press release →

Posted in Business, Healthcare, Pharma & Biotech, Switzerland

Tagged , , , , , ,